X
Xiaoying Li
Researcher at Fudan University
Publications - 232
Citations - 12574
Xiaoying Li is an academic researcher from Fudan University. The author has contributed to research in topics: Diabetes mellitus & Insulin resistance. The author has an hindex of 42, co-authored 192 publications receiving 10218 citations. Previous affiliations of Xiaoying Li include Chinese Academy of Sciences & Xiamen University.
Papers
More filters
Journal ArticleDOI
Polydextrose Alleviates Adipose Tissue Inflammation and Modulates the Gut Microbiota in High-Fat Diet-Fed Mice
Qiuyue Hu,Yixin Niu,Yanxia Yang,Qianyun Mao,Yao Liu,Hui Ran,Hongmei Zhang,Xiaoying Li,Hongxia Gu,Qing Su +9 more
TL;DR: Results indicates that PDX can prevent and treat obesity in HFD-fed mice, specifically in alleviating glucolipid metabolism disorders and adipose tissue inflammation, which may be mediated by modulating the structure of the gut microbiota.
Journal ArticleDOI
Elevated serum γ-glutamyltransferase predicts the development of impaired glucose metabolism in middle-aged and elderly Chinese.
Yu Xu,Min Xu,Yun Huang,Tiange Wang,Mian Li,Yaohua Wu,Aiyun Song,Xiaoying Li,Yufang Bi,Guang Ning +9 more
TL;DR: Serum GGT levels were significantly associated with incident diabetes or combined diabetes and IGR prospectively and a high serum GGT level at baseline was independently associated with an increase in the index of homeostasis model assessment of insulin resistance (HOMA-IR) at follow-up.
Journal ArticleDOI
Assessing the value of bilateral inferior petrosal sinus sampling in the diagnosis and treatment of a complex case of Cushing's disease
Changyan Fan,Chen-ran Zhang,Xiu-hua Shi,Liuguan Bian,Wei-guo Zhao,Hua Zhang,Tingwei Su,Weiqing Wang,Xiaoying Li,Guang Ning,Liang Kong,Lingling Hu,Qingfang Sun +12 more
TL;DR: BIPSS was a useful way to diagnosis Cushing's disease and suggested the exact location of a pituitary adenoma to Neurosurgery and should be a required test for cases of CD that cannot be definitively diagnosed with just an MRI and 8 mg DST before surgery.
Journal ArticleDOI
Dose-response relationship between serum fibroblast growth factor 21 and liver fat content in non-alcoholic fatty liver disease.
F. Xiao,X. Shi,P. Huang,X. Zeng,Liying Wang,Jinyang Zeng,Chang Liu,Bing Yan,Haiqu Song,Y. Xu,Li-li Han,Q. Zhao,M. Lin,Xiaoying Li +13 more
TL;DR: In this paper, the authors explored the potential dose-response relationship between FGF21 and liver fat content in NAFLD patients by using restricted cubic spline regression, and found that changes in serum fibroblast growth factor 21 (FGF21) levels were strongly associated with their corresponding relative IHTG loss at both month 12 and follow-up.
Journal ArticleDOI
Microarray profile of B cells from Graves’ disease patients reveals biomarkers of proliferation
TL;DR: LncRNA and mRNA expression profiles of B cells from patients with Graves’ disease indicated that the lncRNA–mRNA pairs n335641–TCL1A, TCONS_00022357-XLOC_010919-TCL 1A, and n337845–SH2D1A may participate in GD pathogenesis by modulating B-cell proliferation and survival.